Trial intelligence / Profile preview

Albumin for Intracerebral Hemorrhage

NCT00990509Phase 2Terminated

Sponsor
Georgetown University
Start
Sep 2009
Primary completion
Jun 2013
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of albumin (human) in intracerebral hemorrhage (ICH), sponsored by Georgetown University. Started Sep 2009; status: terminated.

02

Drugs

albumin (human)
03

Conditions

intracerebral hemorrhage (ICH)

Beyond the preview

Go deeper on NCT00990509.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00990509.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call